hikma.comHikma in the US Hikma

Share price: 2200p -14p Country sites EN Our international presence Return to Hikma.com Algeria Egypt Germany Iraq Italy Jordan KSA Morocco Portugal Tunisia UAE US EN Home About About us We put better health within reach, every day. We're helping to shape a healthier world that enriches all of our communities. Visit this section About About Our brand Worldwide Leadership Partners History Ethics and compliance Vision and values Hikma Ventures Awards and achievements Our policies and positions Products Our products We develop, manufacture and market a broad range of branded and non-branded generic medicines. Visit this section Products Products US products MENA products Europe products Medicine safety Investors Investors Information and tools including share price information, dividends, and the latest reports, results and news. Visit this section Investors Investors Understanding Hikma 2019 annual report Analyst coverage Results, reports and presentations Financial information Investor tools Regulatory news Calendar Corporate governance Shareholder information Sustainability Sustainability We’re committed to operating sustainably and feel a real duty of care towards our customers, shareholders and other stakeholders. Visit this section Sustainability Sustainability Sustainability report 2019 Our sustainability strategy Operating responsibly and ethically Sustainability governance Aligning with the UN SDGs Other sustainability reports Newsroom Careers Careers We’re a global company, putting better health within reach, every day. Take your next career step with us. Visit this section Careers Careers Working here Hikma culture Join us Our interns Contact Contact us Find contact details for our offices and locations worldwide. Visit this section Contact Contact US locations Europe locations MENA locations Rest of World locations Country sites Back Our international presence Return to Hikma.com Global Algeria Egypt Germany Iraq Italy Jordan KSA Morocco Portugal Tunisia UAE US Follow us instagram Created with Sketch. Hikma Better health. Within reach. Every day. News Hikma and Sun Pharma enter into exclusive licensing agreement for ILUMYA™ for the Middle East and North Africa region News Hikma launches a generic version of Afinitor® Tablets, 2.5mg, 5mg, 7.5mg Update Hikma update regarding COVID-19 Our impact Every day, our medicines are used by approximately 13 million people. The impact we have on people's lives is important, positive and far-reaching. Case study Our support and impact for the Healthy Kitchen Project Case study Our support and impact; improving patient’s access to ritonavir Insight Two ways to minimise the impact of COVID-19 on vulnerable communities News Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP Find out more Who we are. We make high quality medicines and make them accessible to the people that need them. Corporate social responsibility Hikma launches employee matching donation campaign to support local US food banks and pantries Find out more Our commitment to sustainability Find out more We develop, manufacture and market nearly 700 quality branded and non-branded generic medicines worldwide. Hikma Home Back to top Useful links About Products Investors News Careers Contact Our brand Worldwide Leadership Stay in touch Subscribe to our newsletter Follow us instagram Created with Sketch. © Hikma Pharmaceuticals PLC 2019 Terms of use Cookie policy Disclaimer Privacy policy Community guidelines Our website uses cookies to improve your experience. Some of the cookies we use are essential for parts of our website to operate. By using our website without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy ....